Black Diamond Therapeutics (NASDAQ:BDTX) Price Target Raised to $12.00 at HC Wainwright
Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $11.00 to $12.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Several other analysts have also recently issued reports on the stock. Wedbush reaffirmed […]
Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) had its price objective upped by equities researchers at HC Wainwright from $11.00 to $12.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Several other analysts have also recently issued reports on the stock. Wedbush reaffirmed […]
